Oncotelic Therapeutics, Inc.
OTLC· OTC
Filed Mar 15, 2013 · 10-K · 74 days after period end · 0001193125-13-110175
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $42.00K | — | — |
| Net Income | -$1.68M | -$2.35M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Mar 15, 2013 · 74 d after period end